News
Small Cap Stock news
-
Study reinforces need for greater coordination in heart attack care
[ad_1] American Heart Association Scientific Sessions 2022, Abstract 286 Embargoed until 9:42 a.m. CT/ 10:42 a.m. ET Sunday, Nov. 6,…
Read More » -
No difference in heart outcomes found in use of two diuretics to treat blood pressure
[ad_1] Research Highlights: In a study comparing the effectiveness of two high blood pressure medications (both diuretics) among elderly veterans,…
Read More » -
Novel gene-editing therapy shows promise for patients with transthyretin amyloid cardiomyopathy
[ad_1] Research Highlights: In a clinical trial, a single intravenous infusion of NTLA-2001, a novel gene-editing therapy based on CRISPR/Cas9,…
Read More » -
Intravenous iron improved long-term outcomes for people with heart failure and iron deficiency
[ad_1] Research Highlights: Repeated intravenous (IV) administration of iron reduced the risk of hospitalization for heart failure and cardiovascular death…
Read More » -
New medicine reduces triglyceride by 25%, no change in CVD risk in people with Type 2 diabetes
[ad_1] Research Highlights: A new cholesterol medication, pemafibrate, lowered triglyceride levels among adults with Type 2 diabetes, however, there was…
Read More » -
Todos Medical Announces BioFuture NYC 2022 Presentation
[ad_1] New York, NY, and Tel Aviv, ISRAEL – (NewMediaWire) – November 4, 2022 – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive…
Read More » -
Golden Matrix Acquires Remaining Interest in RKings Competitions
[ad_1] LAS VEGAS, NV – (NewMediaWire) – November 04, 2022 – Golden Matrix Group Inc. (NASDAQ:GMGI), a developer and licensor…
Read More » -
iDPRT Provides Solutions for Massive Nucleic Acid Assay
[ad_1] New York, NY – (NewMediaWire) – November 4, 2022 – iDPRT and Dehong Epidemic Prevention Center work together to purchase…
Read More » -
CDSCO India equivalent to US FDA approves Photocil for Sale
Jupiter Wellness, Inc. (Nasdaq: JUPW), has been approved by the CDSCO for sale in India. The Central Drugs Standard Control…
Read More » -
Timber Pharmaceuticals Announces Halt of Common Stock Trading
[ad_1] Compliance with NYSE Listing Requirements Contingent on Stockholder Approval of Reverse Stock Split at Special Meeting of Stockholders on…
Read More »
